Latest News - Boston Scientific
Top Corporates Hub
Boston Scientific
OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands
30.10.2025 16:24
OPKO Health's Q3 earnings top estimates despite lower sales. Cost cuts and product strength boost margins and operating income.
GKOS Stock Surges Following Q3 Earnings & Revenue Beat, Guidance Raised
30.10.2025 16:21
Glaukos reported a narrower Q3 loss, strong 38% sales jump, and raised 2025 outlook as iDose TR and Epioxa fuel momentum across key franchises.
BAX Stock Falls Following Q3 Earnings Beat & Sales Miss, '25 EPS View Down
30.10.2025 14:30
Baxter's Q3 earnings top forecasts, but sales lag and 2025 EPS guidance slips; shares fall despite strength in Pharma and Advanced Surgery.
CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains
30.10.2025 14:29
Cardinal Health delivered a strong Q1 beat and lifted its 2026 EPS outlook, fueled by broad-based growth and rising profits across all business segments.
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls
30.10.2025 13:04
BIO's Q3 earnings fall short of estimates despite higher revenues, as margin pressure and weak research demand weigh on results.
5 Insightful Analyst Questions From Boston Scientific’s Q3 Earnings Call
29.10.2025 05:35
Boston Scientific’s third quarter saw a positive market reaction, reflecting operational execution across multiple business units. Management attributed the strong results to broad-based growth, especially in electrophysiology and the WATCHMAN left atrial appendage closure device, which CEO Michael Mahoney called “a gem for Boston Scientific.” The company also noted resilient demand in the U.S. and Asia Pacific, with double-digit growth in Japan and China. Mahoney emphasized that growth was driv
Is Boston Scientific’s Rally Justified After Another Year of Double Digit Gains?
29.10.2025 01:11
If you are trying to figure out what to do with Boston Scientific stock right now, you are not alone. It is one of those names that investors keep coming back to, especially after a remarkable run in recent years. Just think about it: the stock has climbed an impressive 19.4% in the past year and a staggering 187.3% over five years. Even more, the year-to-date gain of 13.0% and a steady 2.8% in the last 30 days suggest this momentum may have staying power. Behind these moves is a string of...
United States Nebulizer Market Research 2025-2033, Competitive Analysis of OMRON, GE Healthcare, Boston Scientific, Koninklijke Philips, Vectura, Aerogen, DeVilbiss Healthcare, Beurer
27.10.2025 15:48
The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the rising prevalence of respiratory diseases, advancements in nebulizer technology, and an increased focus on home healthcare solutions. Nebulizers offer effective inhalation therapy for conditions like asthma, COPD, and cystic fibrosis. Technological improvements such as smart connectivity and portable designs enhance user convenience,
PAHC vs. BSX: Which Stock Is the Better Value Option?
27.10.2025 15:40
PAHC vs. BSX: Which Stock Is the Better Value Option?
RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised
27.10.2025 14:05
Revvity beats on Q3 earnings and raises 2025 EPS view, as balanced segment performance offsets margin pressure.
Does Boston Scientific (BSX) Have the Potential to Rally 25.61% as Wall Street Analysts Expect?
27.10.2025 13:55
The consensus price target hints at a 25.6% upside potential for Boston Scientific (BSX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?
27.10.2025 13:20
GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.
Boston Scientific: Continuing Its M&A Playbook, As Organic Achievements Impress
24.10.2025 10:11
Boston Scientific shows strong organic growth, margin expansion, and strategic acquisitions, trading at a premium with long-term potential. See why BSX stock is a hold.
Boston Scientific Corporation 2025 Q3 - Results - Earnings Call Presentation
22.10.2025 08:49
2025-10-22. The following slide deck was published by Boston Scientific Corporation in conjunction with their 2025 Q3 earnings call.
HIMS Stock Declines Despite Launch of New Specialty in Women's Health
21.10.2025 14:06
Hims & Hers debuts a new women's health specialty, targeting menopause care with personalized treatment plans.
Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained
21.10.2025 10:33
Boston Scientific Corporation (NYSE:BSX) ranks among the best medical device stocks to invest in. Following an analyst visit to Boston Scientific Corporation (NYSE:BSX)’s headquarters, TD Cowen reaffirmed its Buy rating and $115 price target on the company on October 10. According to the firm, the visit strengthened its belief in Boston Scientific’s outlook, which it […]
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings
21.10.2025 03:08
Medical device company Boston Scientific (NYSE:BSX) will be announcing earnings results this Wednesday morning. Here’s what to expect.